Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study.
about
Pharmacokinetics, safety, and tolerability of faldaprevir in patients with renal impairment.Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis.HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic ImpairmentHCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection.Faldaprevir for the treatment of hepatitis C.Efficacy of Interferon-Free Therapies for Chronic Hepatitis C: A Systematic Review of All Randomized Clinical Trials.Effect of Steady-State Faldaprevir on Pharmacokinetics of Atorvastatin or Rosuvastatin in Healthy Volunteers: A Prospective Open-Label, Fixed-Sequence Crossover Study.Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir.The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes.Investigation of the effect of food and omeprazole on the relative bioavailability of a single oral dose of 240 mg faldaprevir, a selective inhibitor of HCV NS3/4 protease, in an open-label, randomized, three-way cross-over trial in healthy participOpen-label phase 2 study of faldaprevir, deleobuvir and ribavirin in Japanese treatment-naive patients with chronic hepatitis C virus genotype 1 infection.
P2860
Q30614811-EAB2AB2F-1141-4A30-B430-432366325AE2Q30620900-28034EA6-B3E3-4704-BCE0-A00A42F7E58AQ36234703-B1A49753-0ECF-46AA-AF62-74A1BCC00DBCQ37446584-FC3F6C14-B1C8-47FD-B2BC-9D74888D22B8Q38370056-FBBB8714-96B1-40EE-B5DE-C292862E8D9FQ38837174-29A2266E-E5F1-4457-AAAE-5CDF47DDDDCBQ40198351-9C2EFA4A-0A1E-4812-B575-C127F9B75FF9Q40587241-E57B8D51-CC4E-40F4-8E4D-27BB4B644EC5Q40625859-9E6ACC28-B02D-4242-83D2-1E42CE3FBEFAQ40831047-EABE1733-2A75-4CD0-AEFD-A49ACFB2AC84Q41216291-45C1DF01-7158-40A6-B6F0-1A2111CED369
P2860
Interferon-free treatment of chronic hepatitis C with faldaprevir, deleobuvir and ribavirin: SOUND-C3, a Phase 2b study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Interferon-free treatment of c ...... n: SOUND-C3, a Phase 2b study.
@en
type
label
Interferon-free treatment of c ...... n: SOUND-C3, a Phase 2b study.
@en
prefLabel
Interferon-free treatment of c ...... n: SOUND-C3, a Phase 2b study.
@en
P2093
P2860
P356
P1433
P1476
Interferon-free treatment of c ...... n: SOUND-C3, a Phase 2b study.
@en
P2093
Federico J Mensa
Jawahar Taunk
Jerry O Stern
John-Paul Gallivan
Maria Buti
Parvez Mantry
Richard Vinisko
Robert J Buynak
SOUND-C3 study group
Stefan Zeuzem
P2860
P304
P356
10.1111/LIV.12693
P577
2014-10-16T00:00:00Z